Novo Nordisk's Chartres site. (Credit: Novo Nordisk)
November 27, 2023 06:54 AM ESTUpdated 08:38 AM
Manufacturing

No­vo Nordisk in­vests $2.4B in French fa­cil­i­ty to ad­dress boom­ing GLP-1 de­mand

Anna Brown

News Reporter

No­vo Nordisk is spend­ing 16 bil­lion DKK ($2.4 bil­lion) to ex­pand its site in France, which fo­cus­es on mak­ing GLP-1 prod­ucts …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times